• mail us help@statsmarketresearch.com
  • Int'l (+1)-646-781-7170
  • Asia: (+91)-916-916-4321

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Nonalcoholic Steatohepatitis (NASH) Market Insights and Forecast to 2028

Global Nonalcoholic Steatohepatitis (NASH) Market Insights and Forecast to 2028

  • Category:Life Sciences
  • Published on : 14 May 2022
  • Pages :110
  • Formats:
  • Report Code:SMR-7076583
OfferClick for best price

Best Price: $3920

Nonalcoholic Steatohepatitis (NASH) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nonalcoholic Steatohepatitis (NASH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Obeticholic acid?OCA?
Selonsertib
Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy
By Company
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Obeticholic acid?OCA?
1.2.3 Selonsertib
1.3 Market by Application
1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Perspective (2017-2028)
2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Region
2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Region (2017-2022)
2.2.3 Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Region (2023-2028)
2.3 Nonalcoholic Steatohepatitis (NASH) Market Dynamics
2.3.1 Nonalcoholic Steatohepatitis (NASH) Industry Trends
2.3.2 Nonalcoholic Steatohepatitis (NASH) Market Drivers
2.3.3 Nonalcoholic Steatohepatitis (NASH) Market Challenges
2.3.4 Nonalcoholic Steatohepatitis (NASH) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue
3.1.1 Global Top Nonalcoholic Steatohepatitis (NASH) Players by Revenue (2017-2022)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2017-2022)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nonalcoholic Steatohepatitis (NASH) Revenue
3.4 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio
3.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonalcoholic Steatohepatitis (NASH) Revenue in 2021
3.5 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
3.6 Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
3.7 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Type
4.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Type (2017-2022)
4.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2023-2028)
5 Nonalcoholic Steatohepatitis (NASH) Breakdown Data by Application
5.1 Global Nonalcoholic Steatohepatitis (NASH) Historic Market Size by Application (2017-2022)
5.2 Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size (2017-2028)
6.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
6.2.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
6.2.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028)
6.2.3 North America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2017-2028)
6.3 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application
6.3.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
6.3.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028)
6.3.3 North America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2017-2028)
6.4 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
6.4.1 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022)
6.4.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2017-2028)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type
7.2.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
7.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028)
7.2.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2017-2028)
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application
7.3.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
7.3.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028)
7.3.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2017-2028)
7.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country
7.4.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022)
7.4.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size (2017-2028)
8.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type
8.2.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2017-2028)
8.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application
8.3.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2017-2028)
8.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.4.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size (2017-2028)
9.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
9.2.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
9.2.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028)
9.2.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2017-2028)
9.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application
9.3.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
9.3.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028)
9.3.3 Latin America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2017-2028)
9.4 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
9.4.1 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022)
9.4.2 Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size (2017-2028)
10.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type
10.2.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2017-2028)
10.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application
10.3.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2017-2028)
10.4 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country
10.4.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Introduction
11.1.4 AstraZeneca Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Details
11.2.2 Arena Pharmaceuticals Business Overview
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.2.4 Arena Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.2.5 Arena Pharmaceuticals Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Introduction
11.3.4 GSK Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Introduction
11.4.4 Novo Nordisk Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.4.5 Novo Nordisk Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Introduction
11.5.4 Roche Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 Vivus
11.6.1 Vivus Company Details
11.6.2 Vivus Business Overview
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Introduction
11.6.4 Vivus Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.6.5 Vivus Recent Developments
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Details
11.7.2 Arisaph Pharmaceuticals Business Overview
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.7.4 Arisaph Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.7.5 Arisaph Pharmaceuticals Recent Developments
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Details
11.8.2 Cempra Pharmaceuticals Business Overview
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.8.4 Cempra Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.8.5 Cempra Pharmaceuticals Recent Developments
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Details
11.9.2 Galectin Therapeutics Business Overview
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Introduction
11.9.4 Galectin Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.9.5 Galectin Therapeutics Recent Developments
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Details
11.10.2 Galmed Pharmaceuticals Business Overview
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Introduction
11.10.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.10.5 Galmed Pharmaceuticals Recent Developments
11.11 Genfit
11.11.1 Genfit Company Details
11.11.2 Genfit Business Overview
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Introduction
11.11.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.11.5 Genfit Recent Developments
11.12 Gilead
11.12.1 Gilead Company Details
11.12.2 Gilead Business Overview
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Introduction
11.12.4 Gilead Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
11.12.5 Gilead Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Obeticholic acid?OCA?
Table 3. Key Players of Selonsertib
Table 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Region (2017-2022)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Region (2023-2028)
Table 10. Nonalcoholic Steatohepatitis (NASH) Market Trends
Table 11. Nonalcoholic Steatohepatitis (NASH) Market Drivers
Table 12. Nonalcoholic Steatohepatitis (NASH) Market Challenges
Table 13. Nonalcoholic Steatohepatitis (NASH) Market Restraints
Table 14. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players (2017-2022)
Table 16. Global Top Nonalcoholic Steatohepatitis (NASH) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2021)
Table 17. Ranking of Global Top Nonalcoholic Steatohepatitis (NASH) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nonalcoholic Steatohepatitis (NASH) Product Solution and Service
Table 21. Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2017-2022)
Table 25. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type (2023-2028)
Table 27. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2017-2022)
Table 29. Global Nonalcoholic Steatohepatitis (NASH) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Application (2023-2028)
Table 31. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2023-2028) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product
Table 64. AstraZeneca Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 65. AstraZeneca Recent Developments
Table 66. Arena Pharmaceuticals Company Details
Table 67. Arena Pharmaceuticals Business Overview
Table 68. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 69. Arena Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 70. Arena Pharmaceuticals Recent Developments
Table 71. GSK Company Details
Table 72. GSK Business Overview
Table 73. GSK Nonalcoholic Steatohepatitis (NASH) Product
Table 74. GSK Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 75. GSK Recent Developments
Table 76. Novo Nordisk Company Details
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product
Table 79. Novo Nordisk Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 80. Novo Nordisk Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Nonalcoholic Steatohepatitis (NASH) Product
Table 84. Roche Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 85. Roche Recent Developments
Table 86. Vivus Company Details
Table 87. Vivus Business Overview
Table 88. Vivus Nonalcoholic Steatohepatitis (NASH) Product
Table 89. Vivus Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 90. Vivus Recent Developments
Table 91. Arisaph Pharmaceuticals Company Details
Table 92. Arisaph Pharmaceuticals Business Overview
Table 93. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 94. Arisaph Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 95. Arisaph Pharmaceuticals Recent Developments
Table 96. Cempra Pharmaceuticals Company Details
Table 97. Cempra Pharmaceuticals Business Overview
Table 98. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 99. Cempra Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 100. Cempra Pharmaceuticals Recent Developments
Table 101. Galectin Therapeutics Company Details
Table 102. Galectin Therapeutics Business Overview
Table 103. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product
Table 104. Galectin Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 105. Galectin Therapeutics Recent Developments
Table 106. Galmed Pharmaceuticals Company Details
Table 107. Galmed Pharmaceuticals Business Overview
Table 108. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product
Table 109. Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 110. Galmed Pharmaceuticals Recent Developments
Table 111. Genfit Company Details
Table 112. Genfit Business Overview
Table 113. Genfit Nonalcoholic Steatohepatitis (NASH) Product
Table 114. Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 115. Genfit Recent Developments
Table 116. Gilead Company Details
Table 117. Gilead Business Overview
Table 118. Gilead Nonalcoholic Steatohepatitis (NASH) Product
Table 119. Gilead Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022) & (US$ Million)
Table 120. Gilead Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type: 2021 VS 2028
Figure 2. Obeticholic acid?OCA? Features
Figure 3. Selonsertib Features
Figure 4. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application: 2021 VS 2028
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Online Provider Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Figure 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Nonalcoholic Steatohepatitis (NASH) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Region: 2021 VS 2028
Figure 12. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Players in 2021
Figure 13. Global Top Nonalcoholic Steatohepatitis (NASH) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue in 2021
Figure 15. North America Nonalcoholic Steatohepatitis (NASH) Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2028)
Figure 17. North America Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2028)
Figure 18. North America Nonalcoholic Steatohepatitis (NASH) Market Size Share by Country (2017-2028)
Figure 19. United States Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Nonalcoholic Steatohepatitis (NASH) Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2028)
Figure 23. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2028)
Figure 24. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Share by Country (2017-2028)
Figure 25. Germany Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Share by Region (2017-2028)
Figure 35. China Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Nonalcoholic Steatohepatitis (NASH) Market Size Share by Country (2017-2028)
Figure 45. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size Share by Country (2017-2028)
Figure 51. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Nonalcoholic Steatohepatitis (NASH) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AstraZeneca Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 55. Arena Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 56. GSK Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 57. Novo Nordisk Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 58. Roche Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 59. Vivus Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 60. Arisaph Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 61. Cempra Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 62. Galectin Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 63. Galmed Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 64. Genfit Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 65. Gilead Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount